Cases & Deals

  • Home
  • Practices
  • Huadong Medicine enters co-development partnership with Exscientia to accelerate oncology drug discovery through AI

Share

Huadong Medicine enters co-development partnership with Exscientia to accelerate oncology drug discovery through AI

September 2020

Client(s) Huadong Medicine Co. Ltd.

Jones Day advised Huadong Medicine Co. Ltd. in the negotiation and signing of a research cooperation agreement with Exscientia, a world-leading, clinical-stage Artificial Intelligence (AI) drug discovery company.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.